Study – Inhaled budesonide in the treatment of early COVID-19 (STOIC)

Drbeen Medical Lectures | April 15, 2021

Researchers in UK studied the effect of inhaled budesonide in outpatient setting for mild COVID patients. Researchers found out that the early use of inhaled budesnoid reduces the likelihood of needing urgent medical care and reduces time to recovery after early COVID.

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!